Parkwalk Advisors has invested an undisclosed sum in Cardiff ultrasound simulation technology developer MedaPhor through its Opportunities Fund.
MedaPhor, a UK-based ultrasound simulation technology spinout from University of Cardiff, has raised an undisclosed amount from Parkwalk Advisors, the fund management division of commercialisation firm IP Group. Parkwalk invested through its Opportunities Fund, a vehicle set up to receive tax advantages in the UK. Founded in 2004, MedaPhor develops a range of mainly ultrasound-powered…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
